Literature DB >> 1520052

Epidemiology of bacterial endocarditis in The Netherlands. I. Patient characteristics.

J T van der Meer1, J Thompson, H A Valkenburg, M F Michel.   

Abstract

BACKGROUND: Studies of the epidemiology of bacterial endocarditis are usually based on a retrospective review of medical records from referral centers serving diverse patient populations. These studies are therefore likely to suffer from selection bias. We conducted a nationwide prospective epidemiologic study of endocarditis in the Netherlands.
METHODS: During a 2-year period, all cases of consecutively hospitalized patients with suspected endocarditis in the Netherlands were reported to us. While hospitalized, patients were visited for an in-person interview and a review of the medical record.
RESULTS: Of 559 episodes, 438 met the criteria for endocarditis; these included 89 episodes of prosthetic valve endocarditis and 349 episodes of native valve endocarditis. Adjusted for age- and sex-specific population figures, the incidence was 19 per million person-years. The incidence increased significantly with age, and men were more often affected than women (266 and 172 cases, respectively). Rheumatic and congenital cardiac lesions formed most of the underlying heart diseases. Mitral valve prolapse was present in only 29 patients with native valve endocarditis (8.3%). A history of intravenous drug abuse was present in 32 patients (7.3%). Viridans streptococci, staphylococci, and enterococci together constituted 86% of the isolated bacterial strains. Only 1.1% of the patients had culture-negative endocarditis. Overall case fatality was 19.7% and varied widely according to causative microorganism.
CONCLUSION: The distribution of causal microorganisms, the case fatality rate, and the incidence rate of endocarditis are age related. Therefore, a meaningful comparison of data is only possible between population-based cohorts of patients with endocarditis.

Entities:  

Mesh:

Year:  1992        PMID: 1520052     DOI: 10.1001/archinte.152.9.1863

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  49 in total

1.  Streptococcus gordonii biofilm formation: identification of genes that code for biofilm phenotypes.

Authors:  C Y Loo; D A Corliss; N Ganeshkumar
Journal:  J Bacteriol       Date:  2000-03       Impact factor: 3.490

2.  Infective Endocarditis.

Authors: 
Journal:  Curr Treat Options Cardiovasc Med       Date:  1999-10

3.  Trends in hospitalization rates and outcomes of endocarditis among Medicare beneficiaries.

Authors:  Behnood Bikdeli; Yun Wang; Nancy Kim; Mayur M Desai; Vincent Quagliarello; Harlan M Krumholz
Journal:  J Am Coll Cardiol       Date:  2013-08-28       Impact factor: 24.094

4.  Mitral valve reconstruction in the presence of infection.

Authors:  S A Livesey
Journal:  Heart       Date:  2005-10-10       Impact factor: 5.994

Review 5.  The Changing Epidemiology of Infective Endocarditis in the Twenty-First Century.

Authors:  J Ambrosioni; M Hernandez-Meneses; A Téllez; J Pericàs; C Falces; J M Tolosana; B Vidal; M Almela; E Quintana; J Llopis; A Moreno; José M Miro
Journal:  Curr Infect Dis Rep       Date:  2017-05       Impact factor: 3.725

Review 6.  [Diagnosis and treatment of infective endocarditis].

Authors:  D Horstkotte; C Piper
Journal:  Internist (Berl)       Date:  2008-01       Impact factor: 0.743

7.  The risk of infective endocarditis in the 21st century.

Authors:  Nalini M Rajamannan
Journal:  Indian Heart J       Date:  2013-07-25

8.  Immunization with FimA protects against Streptococcus parasanguis endocarditis in rats.

Authors:  H B Viscount; C L Munro; D Burnette-Curley; D L Peterson; F L Macrina
Journal:  Infect Immun       Date:  1997-03       Impact factor: 3.441

9.  Wait, not so fast. Are the new American Heart Association endocarditis prophylaxis guidelines safe, and where is the proof?

Authors:  Roland G Beaulieu
Journal:  Paediatr Child Health       Date:  2009-03       Impact factor: 2.253

10.  Clinical features and outcome of infective endocarditis in yemeni patients treated with empirical antibiotic therapy.

Authors:  Al-Aghbari Khaled; Alezzy Yahya Al-Noami; Mohamed Al-Ansi; Ahmed Askar Faiza
Journal:  Heart Views       Date:  2010-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.